nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—P-Glycoprotein Inhibitors—Vemurafenib—skin cancer	0.756	1	CiPCiCtD
Zonisamide—CYP2C19—Vismodegib—skin cancer	0.014	0.295	CbGbCtD
Zonisamide—CYP3A4—Temozolomide—skin cancer	0.00977	0.206	CbGbCtD
Zonisamide—CYP3A4—Imiquimod—skin cancer	0.00977	0.206	CbGbCtD
Zonisamide—CYP3A4—Vismodegib—skin cancer	0.00677	0.143	CbGbCtD
Zonisamide—CYP3A4—Vemurafenib—skin cancer	0.00535	0.113	CbGbCtD
Zonisamide—CA13—nerve—skin cancer	0.0029	0.058	CbGeAlD
Zonisamide—CA8—blood vessel—skin cancer	0.00266	0.0532	CbGeAlD
Zonisamide—CA6—ear—skin cancer	0.00249	0.0499	CbGeAlD
Zonisamide—CA3—ear—skin cancer	0.00236	0.0472	CbGeAlD
Zonisamide—SCN11A—nerve—skin cancer	0.00199	0.0397	CbGeAlD
Zonisamide—CYP3A4—Docetaxel—skin cancer	0.00184	0.0387	CbGbCtD
Zonisamide—SCN4B—nipple—skin cancer	0.00161	0.0321	CbGeAlD
Zonisamide—CA11—nipple—skin cancer	0.00138	0.0276	CbGeAlD
Zonisamide—CA6—hair follicle—skin cancer	0.00131	0.0263	CbGeAlD
Zonisamide—SCN1B—female reproductive system—skin cancer	0.00102	0.0205	CbGeAlD
Zonisamide—CA10—female reproductive system—skin cancer	0.000982	0.0196	CbGeAlD
Zonisamide—SCN2B—head—skin cancer	0.000946	0.0189	CbGeAlD
Zonisamide—SCN4B—mammalian vulva—skin cancer	0.000938	0.0188	CbGeAlD
Zonisamide—SCN1B—head—skin cancer	0.000855	0.0171	CbGeAlD
Zonisamide—CA1—nerve—skin cancer	0.000834	0.0167	CbGeAlD
Zonisamide—CA10—head—skin cancer	0.00082	0.0164	CbGeAlD
Zonisamide—CA11—mammalian vulva—skin cancer	0.000808	0.0161	CbGeAlD
Zonisamide—CA8—head—skin cancer	0.000804	0.0161	CbGeAlD
Zonisamide—SCN3B—head—skin cancer	0.00079	0.0158	CbGeAlD
Zonisamide—CA5A—female reproductive system—skin cancer	0.000692	0.0138	CbGeAlD
Zonisamide—CA11—female reproductive system—skin cancer	0.000692	0.0138	CbGeAlD
Zonisamide—CA13—head—skin cancer	0.000688	0.0138	CbGeAlD
Zonisamide—MAOB—nerve—skin cancer	0.000677	0.0135	CbGeAlD
Zonisamide—SCN4B—head—skin cancer	0.000671	0.0134	CbGeAlD
Zonisamide—CA4—nerve—skin cancer	0.000652	0.013	CbGeAlD
Zonisamide—SCN1B—lymph node—skin cancer	0.000599	0.012	CbGeAlD
Zonisamide—CA3—connective tissue—skin cancer	0.000599	0.012	CbGeAlD
Zonisamide—CA11—head—skin cancer	0.000578	0.0116	CbGeAlD
Zonisamide—MAOA—nerve—skin cancer	0.000577	0.0115	CbGeAlD
Zonisamide—CA8—lymph node—skin cancer	0.000563	0.0113	CbGeAlD
Zonisamide—SCN3B—lymph node—skin cancer	0.000553	0.0111	CbGeAlD
Zonisamide—AOX1—nipple—skin cancer	0.000499	0.00997	CbGeAlD
Zonisamide—CA13—lymph node—skin cancer	0.000482	0.00964	CbGeAlD
Zonisamide—SCN11A—head—skin cancer	0.000471	0.00942	CbGeAlD
Zonisamide—SCN4B—lymph node—skin cancer	0.00047	0.0094	CbGeAlD
Zonisamide—CACNA1I—lymph node—skin cancer	0.000459	0.00918	CbGeAlD
Zonisamide—CA2—hair follicle—skin cancer	0.000453	0.00905	CbGeAlD
Zonisamide—CACNA1G—head—skin cancer	0.000449	0.00898	CbGeAlD
Zonisamide—CA12—connective tissue—skin cancer	0.000424	0.00847	CbGeAlD
Zonisamide—CA11—lymph node—skin cancer	0.000405	0.00809	CbGeAlD
Zonisamide—CA9—female reproductive system—skin cancer	0.000404	0.00808	CbGeAlD
Zonisamide—MAOB—nipple—skin cancer	0.000384	0.00768	CbGeAlD
Zonisamide—CA6—head—skin cancer	0.000372	0.00744	CbGeAlD
Zonisamide—CA4—nipple—skin cancer	0.00037	0.0074	CbGeAlD
Zonisamide—CA4—neck—skin cancer	0.000366	0.00732	CbGeAlD
Zonisamide—CA3—head—skin cancer	0.000353	0.00705	CbGeAlD
Zonisamide—CACNA1H—female reproductive system—skin cancer	0.000352	0.00704	CbGeAlD
Zonisamide—MAOA—nipple—skin cancer	0.000328	0.00655	CbGeAlD
Zonisamide—MAOA—neck—skin cancer	0.000324	0.00648	CbGeAlD
Zonisamide—CA5B—mammalian vulva—skin cancer	0.000313	0.00626	CbGeAlD
Zonisamide—CA2—nipple—skin cancer	0.000307	0.00613	CbGeAlD
Zonisamide—CA2—neck—skin cancer	0.000304	0.00607	CbGeAlD
Zonisamide—CA12—female reproductive system—skin cancer	0.000299	0.00598	CbGeAlD
Zonisamide—AOX1—mammalian vulva—skin cancer	0.000291	0.00582	CbGeAlD
Zonisamide—SCN4A—head—skin cancer	0.00028	0.0056	CbGeAlD
Zonisamide—MAOB—connective tissue—skin cancer	0.000272	0.00545	CbGeAlD
Zonisamide—SCN1A—head—skin cancer	0.00027	0.0054	CbGeAlD
Zonisamide—CA5B—female reproductive system—skin cancer	0.000268	0.00536	CbGeAlD
Zonisamide—SCN3A—female reproductive system—skin cancer	0.000261	0.00521	CbGeAlD
Zonisamide—CA12—head—skin cancer	0.00025	0.00499	CbGeAlD
Zonisamide—AOX1—female reproductive system—skin cancer	0.000249	0.00499	CbGeAlD
Zonisamide—SCN2A—head—skin cancer	0.000248	0.00495	CbGeAlD
Zonisamide—CA3—lymph node—skin cancer	0.000247	0.00494	CbGeAlD
Zonisamide—CA1—lymphoid tissue—skin cancer	0.000246	0.00491	CbGeAlD
Zonisamide—CA1—female reproductive system—skin cancer	0.000237	0.00473	CbGeAlD
Zonisamide—MAOA—connective tissue—skin cancer	0.000232	0.00465	CbGeAlD
Zonisamide—MAOB—mammalian vulva—skin cancer	0.000224	0.00449	CbGeAlD
Zonisamide—CA5B—head—skin cancer	0.000224	0.00448	CbGeAlD
Zonisamide—SCN9A—lymph node—skin cancer	0.00022	0.00439	CbGeAlD
Zonisamide—SCN3A—head—skin cancer	0.000218	0.00435	CbGeAlD
Zonisamide—CA2—connective tissue—skin cancer	0.000218	0.00435	CbGeAlD
Zonisamide—SCN5A—head—skin cancer	0.000217	0.00434	CbGeAlD
Zonisamide—CA2—epithelium—skin cancer	0.000207	0.00413	CbGeAlD
Zonisamide—CACNA1H—lymph node—skin cancer	0.000206	0.00412	CbGeAlD
Zonisamide—CA1—head—skin cancer	0.000198	0.00396	CbGeAlD
Zonisamide—CA2—skin of body—skin cancer	0.000196	0.00393	CbGeAlD
Zonisamide—MAOB—female reproductive system—skin cancer	0.000192	0.00384	CbGeAlD
Zonisamide—MAOA—mammalian vulva—skin cancer	0.000191	0.00383	CbGeAlD
Zonisamide—CA4—female reproductive system—skin cancer	0.000185	0.0037	CbGeAlD
Zonisamide—CA2—mammalian vulva—skin cancer	0.000179	0.00358	CbGeAlD
Zonisamide—MAOA—female reproductive system—skin cancer	0.000164	0.00328	CbGeAlD
Zonisamide—MAOB—head—skin cancer	0.000161	0.00321	CbGeAlD
Zonisamide—CA2—lymphoid tissue—skin cancer	0.000159	0.00318	CbGeAlD
Zonisamide—CA5B—lymph node—skin cancer	0.000157	0.00314	CbGeAlD
Zonisamide—CA4—head—skin cancer	0.000155	0.00309	CbGeAlD
Zonisamide—CA2—female reproductive system—skin cancer	0.000153	0.00307	CbGeAlD
Zonisamide—SCN3A—lymph node—skin cancer	0.000152	0.00305	CbGeAlD
Zonisamide—AOX1—lymph node—skin cancer	0.000146	0.00292	CbGeAlD
Zonisamide—CA1—lymph node—skin cancer	0.000139	0.00277	CbGeAlD
Zonisamide—MAOA—head—skin cancer	0.000137	0.00274	CbGeAlD
Zonisamide—Hyponatraemia—Docetaxel—skin cancer	0.000129	0.00142	CcSEcCtD
Zonisamide—CA2—head—skin cancer	0.000128	0.00256	CbGeAlD
Zonisamide—Agranulocytosis—Fluorouracil—skin cancer	0.000128	0.00141	CcSEcCtD
Zonisamide—Ill-defined disorder—Bleomycin—skin cancer	0.000128	0.00141	CcSEcCtD
Zonisamide—Anaemia—Bleomycin—skin cancer	0.000127	0.0014	CcSEcCtD
Zonisamide—Diarrhoea—Vemurafenib—skin cancer	0.000127	0.0014	CcSEcCtD
Zonisamide—Erythema multiforme—Temozolomide—skin cancer	0.000126	0.00139	CcSEcCtD
Zonisamide—Urticaria—Imiquimod—skin cancer	0.000126	0.00139	CcSEcCtD
Zonisamide—Body temperature increased—Imiquimod—skin cancer	0.000125	0.00138	CcSEcCtD
Zonisamide—Abdominal pain—Imiquimod—skin cancer	0.000125	0.00138	CcSEcCtD
Zonisamide—Eye disorder—Temozolomide—skin cancer	0.000125	0.00138	CcSEcCtD
Zonisamide—Tinnitus—Temozolomide—skin cancer	0.000125	0.00137	CcSEcCtD
Zonisamide—Malaise—Bleomycin—skin cancer	0.000124	0.00137	CcSEcCtD
Zonisamide—Leukopenia—Bleomycin—skin cancer	0.000123	0.00136	CcSEcCtD
Zonisamide—Rhinitis—Fluorouracil—skin cancer	0.000123	0.00136	CcSEcCtD
Zonisamide—Dizziness—Vemurafenib—skin cancer	0.000123	0.00135	CcSEcCtD
Zonisamide—Pharyngitis—Fluorouracil—skin cancer	0.000122	0.00135	CcSEcCtD
Zonisamide—Ataxia—Docetaxel—skin cancer	0.000121	0.00133	CcSEcCtD
Zonisamide—Immune system disorder—Temozolomide—skin cancer	0.000121	0.00133	CcSEcCtD
Zonisamide—Mediastinal disorder—Temozolomide—skin cancer	0.00012	0.00133	CcSEcCtD
Zonisamide—Cough—Bleomycin—skin cancer	0.00012	0.00133	CcSEcCtD
Zonisamide—Dehydration—Docetaxel—skin cancer	0.000119	0.00132	CcSEcCtD
Zonisamide—Ill-defined disorder—Dactinomycin—skin cancer	0.000119	0.00132	CcSEcCtD
Zonisamide—Anaemia—Dactinomycin—skin cancer	0.000119	0.00131	CcSEcCtD
Zonisamide—Liver function test abnormal—Docetaxel—skin cancer	0.000119	0.00131	CcSEcCtD
Zonisamide—Vomiting—Vemurafenib—skin cancer	0.000118	0.0013	CcSEcCtD
Zonisamide—Alopecia—Temozolomide—skin cancer	0.000118	0.0013	CcSEcCtD
Zonisamide—Dry skin—Docetaxel—skin cancer	0.000118	0.0013	CcSEcCtD
Zonisamide—Myalgia—Bleomycin—skin cancer	0.000117	0.00129	CcSEcCtD
Zonisamide—Chest pain—Bleomycin—skin cancer	0.000117	0.00129	CcSEcCtD
Zonisamide—Rash—Vemurafenib—skin cancer	0.000117	0.00129	CcSEcCtD
Zonisamide—Mental disorder—Temozolomide—skin cancer	0.000117	0.00129	CcSEcCtD
Zonisamide—Dermatitis—Vemurafenib—skin cancer	0.000117	0.00129	CcSEcCtD
Zonisamide—Hypersensitivity—Imiquimod—skin cancer	0.000117	0.00129	CcSEcCtD
Zonisamide—Headache—Vemurafenib—skin cancer	0.000116	0.00128	CcSEcCtD
Zonisamide—Malnutrition—Temozolomide—skin cancer	0.000116	0.00128	CcSEcCtD
Zonisamide—Discomfort—Bleomycin—skin cancer	0.000116	0.00128	CcSEcCtD
Zonisamide—Malaise—Dactinomycin—skin cancer	0.000116	0.00128	CcSEcCtD
Zonisamide—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000116	0.00127	CcSEcCtD
Zonisamide—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000116	0.00127	CcSEcCtD
Zonisamide—Leukopenia—Dactinomycin—skin cancer	0.000115	0.00127	CcSEcCtD
Zonisamide—Dysgeusia—Temozolomide—skin cancer	0.000114	0.00126	CcSEcCtD
Zonisamide—Asthenia—Imiquimod—skin cancer	0.000114	0.00125	CcSEcCtD
Zonisamide—Confusional state—Bleomycin—skin cancer	0.000113	0.00125	CcSEcCtD
Zonisamide—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000113	0.00125	CcSEcCtD
Zonisamide—Oedema—Bleomycin—skin cancer	0.000112	0.00124	CcSEcCtD
Zonisamide—MAOB—lymph node—skin cancer	0.000112	0.00225	CbGeAlD
Zonisamide—Pruritus—Imiquimod—skin cancer	0.000112	0.00124	CcSEcCtD
Zonisamide—Infection—Bleomycin—skin cancer	0.000112	0.00123	CcSEcCtD
Zonisamide—Dysphagia—Docetaxel—skin cancer	0.000111	0.00122	CcSEcCtD
Zonisamide—Nausea—Vemurafenib—skin cancer	0.00011	0.00122	CcSEcCtD
Zonisamide—Thrombocytopenia—Bleomycin—skin cancer	0.00011	0.00121	CcSEcCtD
Zonisamide—Myalgia—Dactinomycin—skin cancer	0.000109	0.00121	CcSEcCtD
Zonisamide—Tremor—Temozolomide—skin cancer	0.000109	0.0012	CcSEcCtD
Zonisamide—Alopecia—Fluorouracil—skin cancer	0.000109	0.0012	CcSEcCtD
Zonisamide—Diarrhoea—Imiquimod—skin cancer	0.000108	0.00119	CcSEcCtD
Zonisamide—CA4—lymph node—skin cancer	0.000108	0.00216	CbGeAlD
Zonisamide—Discomfort—Dactinomycin—skin cancer	0.000108	0.00119	CcSEcCtD
Zonisamide—Ill-defined disorder—Temozolomide—skin cancer	0.000108	0.00119	CcSEcCtD
Zonisamide—Anaemia—Temozolomide—skin cancer	0.000107	0.00119	CcSEcCtD
Zonisamide—Anorexia—Bleomycin—skin cancer	0.000107	0.00118	CcSEcCtD
Zonisamide—Agitation—Temozolomide—skin cancer	0.000107	0.00118	CcSEcCtD
Zonisamide—Pancytopenia—Docetaxel—skin cancer	0.000105	0.00116	CcSEcCtD
Zonisamide—Hypotension—Bleomycin—skin cancer	0.000105	0.00116	CcSEcCtD
Zonisamide—Oedema—Dactinomycin—skin cancer	0.000105	0.00116	CcSEcCtD
Zonisamide—Malaise—Temozolomide—skin cancer	0.000105	0.00116	CcSEcCtD
Zonisamide—Dizziness—Imiquimod—skin cancer	0.000105	0.00115	CcSEcCtD
Zonisamide—Vertigo—Temozolomide—skin cancer	0.000104	0.00115	CcSEcCtD
Zonisamide—Infection—Dactinomycin—skin cancer	0.000104	0.00115	CcSEcCtD
Zonisamide—Leukopenia—Temozolomide—skin cancer	0.000104	0.00115	CcSEcCtD
Zonisamide—Palpitations—Temozolomide—skin cancer	0.000103	0.00113	CcSEcCtD
Zonisamide—Thrombocytopenia—Dactinomycin—skin cancer	0.000103	0.00113	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000102	0.00113	CcSEcCtD
Zonisamide—Cough—Temozolomide—skin cancer	0.000101	0.00112	CcSEcCtD
Zonisamide—Paraesthesia—Bleomycin—skin cancer	0.000101	0.00111	CcSEcCtD
Zonisamide—Weight increased—Docetaxel—skin cancer	0.000101	0.00111	CcSEcCtD
Zonisamide—Convulsion—Temozolomide—skin cancer	0.000101	0.00111	CcSEcCtD
Zonisamide—Vomiting—Imiquimod—skin cancer	0.000101	0.00111	CcSEcCtD
Zonisamide—Weight decreased—Docetaxel—skin cancer	0.0001	0.00111	CcSEcCtD
Zonisamide—Hypertension—Temozolomide—skin cancer	0.0001	0.00111	CcSEcCtD
Zonisamide—Dyspnoea—Bleomycin—skin cancer	0.0001	0.00111	CcSEcCtD
Zonisamide—Anorexia—Dactinomycin—skin cancer	0.0001	0.0011	CcSEcCtD
Zonisamide—Rash—Imiquimod—skin cancer	9.98e-05	0.0011	CcSEcCtD
Zonisamide—Dermatitis—Imiquimod—skin cancer	9.97e-05	0.0011	CcSEcCtD
Zonisamide—Pneumonia—Docetaxel—skin cancer	9.95e-05	0.0011	CcSEcCtD
Zonisamide—Headache—Imiquimod—skin cancer	9.92e-05	0.00109	CcSEcCtD
Zonisamide—CYP3A4—female reproductive system—skin cancer	9.9e-05	0.00198	CbGeAlD
Zonisamide—Anaemia—Fluorouracil—skin cancer	9.9e-05	0.00109	CcSEcCtD
Zonisamide—Arthralgia—Temozolomide—skin cancer	9.9e-05	0.00109	CcSEcCtD
Zonisamide—Myalgia—Temozolomide—skin cancer	9.9e-05	0.00109	CcSEcCtD
Zonisamide—Anxiety—Temozolomide—skin cancer	9.86e-05	0.00109	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	9.83e-05	0.00108	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Docetaxel—skin cancer	9.81e-05	0.00108	CcSEcCtD
Zonisamide—Discomfort—Temozolomide—skin cancer	9.78e-05	0.00108	CcSEcCtD
Zonisamide—Decreased appetite—Bleomycin—skin cancer	9.78e-05	0.00108	CcSEcCtD
Zonisamide—Renal failure—Docetaxel—skin cancer	9.72e-05	0.00107	CcSEcCtD
Zonisamide—Neuropathy peripheral—Docetaxel—skin cancer	9.7e-05	0.00107	CcSEcCtD
Zonisamide—Dry mouth—Temozolomide—skin cancer	9.68e-05	0.00107	CcSEcCtD
Zonisamide—Stomatitis—Docetaxel—skin cancer	9.64e-05	0.00106	CcSEcCtD
Zonisamide—Conjunctivitis—Docetaxel—skin cancer	9.62e-05	0.00106	CcSEcCtD
Zonisamide—MAOA—lymph node—skin cancer	9.59e-05	0.00192	CbGeAlD
Zonisamide—Leukopenia—Fluorouracil—skin cancer	9.59e-05	0.00106	CcSEcCtD
Zonisamide—Confusional state—Temozolomide—skin cancer	9.57e-05	0.00106	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Dactinomycin—skin cancer	9.56e-05	0.00105	CcSEcCtD
Zonisamide—Oedema—Temozolomide—skin cancer	9.49e-05	0.00105	CcSEcCtD
Zonisamide—Infection—Temozolomide—skin cancer	9.42e-05	0.00104	CcSEcCtD
Zonisamide—Nausea—Imiquimod—skin cancer	9.4e-05	0.00104	CcSEcCtD
Zonisamide—Hepatobiliary disease—Docetaxel—skin cancer	9.36e-05	0.00103	CcSEcCtD
Zonisamide—Nervous system disorder—Temozolomide—skin cancer	9.3e-05	0.00103	CcSEcCtD
Zonisamide—Thrombocytopenia—Temozolomide—skin cancer	9.29e-05	0.00102	CcSEcCtD
Zonisamide—Convulsion—Fluorouracil—skin cancer	9.28e-05	0.00102	CcSEcCtD
Zonisamide—Feeling abnormal—Bleomycin—skin cancer	9.27e-05	0.00102	CcSEcCtD
Zonisamide—Agranulocytosis—Docetaxel—skin cancer	9.23e-05	0.00102	CcSEcCtD
Zonisamide—Skin disorder—Temozolomide—skin cancer	9.21e-05	0.00102	CcSEcCtD
Zonisamide—Hyperhidrosis—Temozolomide—skin cancer	9.17e-05	0.00101	CcSEcCtD
Zonisamide—Myalgia—Fluorouracil—skin cancer	9.12e-05	0.00101	CcSEcCtD
Zonisamide—Chest pain—Fluorouracil—skin cancer	9.12e-05	0.00101	CcSEcCtD
Zonisamide—Decreased appetite—Dactinomycin—skin cancer	9.12e-05	0.00101	CcSEcCtD
Zonisamide—Fatigue—Dactinomycin—skin cancer	9.04e-05	0.000997	CcSEcCtD
Zonisamide—Anorexia—Temozolomide—skin cancer	9.04e-05	0.000997	CcSEcCtD
Zonisamide—Discomfort—Fluorouracil—skin cancer	9.01e-05	0.000994	CcSEcCtD
Zonisamide—CA2—lymph node—skin cancer	8.98e-05	0.00179	CbGeAlD
Zonisamide—Urticaria—Bleomycin—skin cancer	8.93e-05	0.000985	CcSEcCtD
Zonisamide—Rhinitis—Docetaxel—skin cancer	8.9e-05	0.000982	CcSEcCtD
Zonisamide—Body temperature increased—Bleomycin—skin cancer	8.89e-05	0.000981	CcSEcCtD
Zonisamide—Confusional state—Fluorouracil—skin cancer	8.81e-05	0.000972	CcSEcCtD
Zonisamide—Pharyngitis—Docetaxel—skin cancer	8.81e-05	0.000972	CcSEcCtD
Zonisamide—Urinary tract disorder—Docetaxel—skin cancer	8.77e-05	0.000967	CcSEcCtD
Zonisamide—Oedema peripheral—Docetaxel—skin cancer	8.75e-05	0.000965	CcSEcCtD
Zonisamide—Oedema—Fluorouracil—skin cancer	8.74e-05	0.000964	CcSEcCtD
Zonisamide—Connective tissue disorder—Docetaxel—skin cancer	8.73e-05	0.000963	CcSEcCtD
Zonisamide—Urethral disorder—Docetaxel—skin cancer	8.7e-05	0.00096	CcSEcCtD
Zonisamide—CA3—Metabolism—CSPG4—skin cancer	8.7e-05	0.00155	CbGpPWpGaD
Zonisamide—Infection—Fluorouracil—skin cancer	8.68e-05	0.000958	CcSEcCtD
Zonisamide—Feeling abnormal—Dactinomycin—skin cancer	8.64e-05	0.000953	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Temozolomide—skin cancer	8.64e-05	0.000953	CcSEcCtD
Zonisamide—Insomnia—Temozolomide—skin cancer	8.58e-05	0.000946	CcSEcCtD
Zonisamide—Gastrointestinal pain—Dactinomycin—skin cancer	8.58e-05	0.000946	CcSEcCtD
Zonisamide—Nervous system disorder—Fluorouracil—skin cancer	8.57e-05	0.000946	CcSEcCtD
Zonisamide—Thrombocytopenia—Fluorouracil—skin cancer	8.56e-05	0.000944	CcSEcCtD
Zonisamide—Tachycardia—Fluorouracil—skin cancer	8.53e-05	0.000941	CcSEcCtD
Zonisamide—SCN1A—Axon guidance—RASA1—skin cancer	8.52e-05	0.00152	CbGpPWpGaD
Zonisamide—Paraesthesia—Temozolomide—skin cancer	8.52e-05	0.00094	CcSEcCtD
Zonisamide—CA1—C-MYB transcription factor network—PTGS2—skin cancer	8.51e-05	0.00152	CbGpPWpGaD
Zonisamide—Dyspnoea—Temozolomide—skin cancer	8.46e-05	0.000933	CcSEcCtD
Zonisamide—Somnolence—Temozolomide—skin cancer	8.43e-05	0.00093	CcSEcCtD
Zonisamide—Erythema multiforme—Docetaxel—skin cancer	8.4e-05	0.000926	CcSEcCtD
Zonisamide—Dyspepsia—Temozolomide—skin cancer	8.35e-05	0.000921	CcSEcCtD
Zonisamide—Anorexia—Fluorouracil—skin cancer	8.33e-05	0.000919	CcSEcCtD
Zonisamide—Eye disorder—Docetaxel—skin cancer	8.3e-05	0.000915	CcSEcCtD
Zonisamide—Abdominal pain—Dactinomycin—skin cancer	8.29e-05	0.000915	CcSEcCtD
Zonisamide—Body temperature increased—Dactinomycin—skin cancer	8.29e-05	0.000915	CcSEcCtD
Zonisamide—Hypersensitivity—Bleomycin—skin cancer	8.29e-05	0.000914	CcSEcCtD
Zonisamide—CACNA1G—NCAM signaling for neurite out-growth—KRAS—skin cancer	8.28e-05	0.00148	CbGpPWpGaD
Zonisamide—Decreased appetite—Temozolomide—skin cancer	8.25e-05	0.00091	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Temozolomide—skin cancer	8.19e-05	0.000903	CcSEcCtD
Zonisamide—Fatigue—Temozolomide—skin cancer	8.18e-05	0.000902	CcSEcCtD
Zonisamide—Hypotension—Fluorouracil—skin cancer	8.17e-05	0.000901	CcSEcCtD
Zonisamide—SCN2B—Axon guidance—NRAS—skin cancer	8.15e-05	0.00145	CbGpPWpGaD
Zonisamide—SCN1B—Axon guidance—NRAS—skin cancer	8.15e-05	0.00145	CbGpPWpGaD
Zonisamide—Constipation—Temozolomide—skin cancer	8.11e-05	0.000895	CcSEcCtD
Zonisamide—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—skin cancer	8.11e-05	0.00145	CbGpPWpGaD
Zonisamide—Asthenia—Bleomycin—skin cancer	8.07e-05	0.00089	CcSEcCtD
Zonisamide—Immune system disorder—Docetaxel—skin cancer	8.02e-05	0.000885	CcSEcCtD
Zonisamide—CACNA1H—NCAM signaling for neurite out-growth—KRAS—skin cancer	8.02e-05	0.00143	CbGpPWpGaD
Zonisamide—Mediastinal disorder—Docetaxel—skin cancer	8e-05	0.000883	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Fluorouracil—skin cancer	7.96e-05	0.000878	CcSEcCtD
Zonisamide—Pruritus—Bleomycin—skin cancer	7.96e-05	0.000878	CcSEcCtD
Zonisamide—Insomnia—Fluorouracil—skin cancer	7.91e-05	0.000872	CcSEcCtD
Zonisamide—Paraesthesia—Fluorouracil—skin cancer	7.85e-05	0.000866	CcSEcCtD
Zonisamide—Alopecia—Docetaxel—skin cancer	7.85e-05	0.000866	CcSEcCtD
Zonisamide—Feeling abnormal—Temozolomide—skin cancer	7.82e-05	0.000862	CcSEcCtD
Zonisamide—Dyspnoea—Fluorouracil—skin cancer	7.79e-05	0.00086	CcSEcCtD
Zonisamide—Mental disorder—Docetaxel—skin cancer	7.78e-05	0.000858	CcSEcCtD
Zonisamide—Somnolence—Fluorouracil—skin cancer	7.77e-05	0.000857	CcSEcCtD
Zonisamide—Gastrointestinal pain—Temozolomide—skin cancer	7.76e-05	0.000856	CcSEcCtD
Zonisamide—Malnutrition—Docetaxel—skin cancer	7.73e-05	0.000853	CcSEcCtD
Zonisamide—Hypersensitivity—Dactinomycin—skin cancer	7.73e-05	0.000852	CcSEcCtD
Zonisamide—Dyspepsia—Fluorouracil—skin cancer	7.69e-05	0.000849	CcSEcCtD
Zonisamide—Decreased appetite—Fluorouracil—skin cancer	7.6e-05	0.000838	CcSEcCtD
Zonisamide—Dysgeusia—Docetaxel—skin cancer	7.57e-05	0.000835	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Fluorouracil—skin cancer	7.55e-05	0.000832	CcSEcCtD
Zonisamide—Urticaria—Temozolomide—skin cancer	7.54e-05	0.000831	CcSEcCtD
Zonisamide—Asthenia—Dactinomycin—skin cancer	7.53e-05	0.00083	CcSEcCtD
Zonisamide—Abdominal pain—Temozolomide—skin cancer	7.5e-05	0.000827	CcSEcCtD
Zonisamide—Body temperature increased—Temozolomide—skin cancer	7.5e-05	0.000827	CcSEcCtD
Zonisamide—SCN4B—Axon guidance—NRAS—skin cancer	7.45e-05	0.00133	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—SCN10A—skin cancer	7.44e-05	0.00133	CbGpPWpGaD
Zonisamide—Muscle spasms—Docetaxel—skin cancer	7.43e-05	0.00082	CcSEcCtD
Zonisamide—CACNA1G—Developmental Biology—RASA1—skin cancer	7.22e-05	0.00129	CbGpPWpGaD
Zonisamide—Feeling abnormal—Fluorouracil—skin cancer	7.2e-05	0.000795	CcSEcCtD
Zonisamide—Diarrhoea—Dactinomycin—skin cancer	7.18e-05	0.000792	CcSEcCtD
Zonisamide—Vomiting—Bleomycin—skin cancer	7.15e-05	0.000789	CcSEcCtD
Zonisamide—Anaemia—Docetaxel—skin cancer	7.14e-05	0.000788	CcSEcCtD
Zonisamide—Rash—Bleomycin—skin cancer	7.09e-05	0.000782	CcSEcCtD
Zonisamide—Dermatitis—Bleomycin—skin cancer	7.08e-05	0.000781	CcSEcCtD
Zonisamide—CACNA1G—NCAM signaling for neurite out-growth—HRAS—skin cancer	7.03e-05	0.00125	CbGpPWpGaD
Zonisamide—SCN2B—Axon guidance—KRAS—skin cancer	7.01e-05	0.00125	CbGpPWpGaD
Zonisamide—SCN1B—Axon guidance—KRAS—skin cancer	7.01e-05	0.00125	CbGpPWpGaD
Zonisamide—Hypersensitivity—Temozolomide—skin cancer	6.99e-05	0.000771	CcSEcCtD
Zonisamide—CACNA1H—Developmental Biology—RASA1—skin cancer	6.99e-05	0.00125	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PLIN2—skin cancer	6.96e-05	0.00124	CbGpPWpGaD
Zonisamide—Urticaria—Fluorouracil—skin cancer	6.94e-05	0.000766	CcSEcCtD
Zonisamide—Syncope—Docetaxel—skin cancer	6.93e-05	0.000765	CcSEcCtD
Zonisamide—SCN3B—Axon guidance—NRAS—skin cancer	6.93e-05	0.00124	CbGpPWpGaD
Zonisamide—Leukopenia—Docetaxel—skin cancer	6.92e-05	0.000763	CcSEcCtD
Zonisamide—Body temperature increased—Fluorouracil—skin cancer	6.91e-05	0.000762	CcSEcCtD
Zonisamide—SCN9A—Developmental Biology—RASA1—skin cancer	6.86e-05	0.00122	CbGpPWpGaD
Zonisamide—Palpitations—Docetaxel—skin cancer	6.83e-05	0.000754	CcSEcCtD
Zonisamide—CACNA1H—NCAM signaling for neurite out-growth—HRAS—skin cancer	6.81e-05	0.00121	CbGpPWpGaD
Zonisamide—Asthenia—Temozolomide—skin cancer	6.81e-05	0.000751	CcSEcCtD
Zonisamide—Loss of consciousness—Docetaxel—skin cancer	6.79e-05	0.000749	CcSEcCtD
Zonisamide—CA6—Metabolism—PLIN2—skin cancer	6.78e-05	0.00121	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PLIN2—skin cancer	6.78e-05	0.00121	CbGpPWpGaD
Zonisamide—Cough—Docetaxel—skin cancer	6.75e-05	0.000744	CcSEcCtD
Zonisamide—CACNA1G—NCAM signaling for neurite out-growth—IL6—skin cancer	6.73e-05	0.0012	CbGpPWpGaD
Zonisamide—Pruritus—Temozolomide—skin cancer	6.71e-05	0.00074	CcSEcCtD
Zonisamide—Convulsion—Docetaxel—skin cancer	6.7e-05	0.000739	CcSEcCtD
Zonisamide—Nausea—Bleomycin—skin cancer	6.68e-05	0.000737	CcSEcCtD
Zonisamide—Hypertension—Docetaxel—skin cancer	6.67e-05	0.000736	CcSEcCtD
Zonisamide—Vomiting—Dactinomycin—skin cancer	6.67e-05	0.000736	CcSEcCtD
Zonisamide—CA1—C-MYB transcription factor network—NRAS—skin cancer	6.62e-05	0.00118	CbGpPWpGaD
Zonisamide—Rash—Dactinomycin—skin cancer	6.61e-05	0.000729	CcSEcCtD
Zonisamide—Chest pain—Docetaxel—skin cancer	6.58e-05	0.000726	CcSEcCtD
Zonisamide—Myalgia—Docetaxel—skin cancer	6.58e-05	0.000726	CcSEcCtD
Zonisamide—Arthralgia—Docetaxel—skin cancer	6.58e-05	0.000726	CcSEcCtD
Zonisamide—SCN3A—Developmental Biology—RASA1—skin cancer	6.57e-05	0.00117	CbGpPWpGaD
Zonisamide—CA13—Metabolism—ERCC2—skin cancer	6.54e-05	0.00117	CbGpPWpGaD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	6.54e-05	0.000721	CcSEcCtD
Zonisamide—CACNA1H—NCAM signaling for neurite out-growth—IL6—skin cancer	6.52e-05	0.00116	CbGpPWpGaD
Zonisamide—Diarrhoea—Temozolomide—skin cancer	6.49e-05	0.000716	CcSEcCtD
Zonisamide—Hypersensitivity—Fluorouracil—skin cancer	6.44e-05	0.00071	CcSEcCtD
Zonisamide—Dry mouth—Docetaxel—skin cancer	6.44e-05	0.00071	CcSEcCtD
Zonisamide—SCN4B—Axon guidance—KRAS—skin cancer	6.41e-05	0.00114	CbGpPWpGaD
Zonisamide—Confusional state—Docetaxel—skin cancer	6.36e-05	0.000702	CcSEcCtD
Zonisamide—CA5B—Metabolism—PLIN2—skin cancer	6.33e-05	0.00113	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PLIN2—skin cancer	6.33e-05	0.00113	CbGpPWpGaD
Zonisamide—Oedema—Docetaxel—skin cancer	6.31e-05	0.000696	CcSEcCtD
Zonisamide—SCN4A—Developmental Biology—RASA1—skin cancer	6.31e-05	0.00112	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—RASA1—skin cancer	6.31e-05	0.00112	CbGpPWpGaD
Zonisamide—Dizziness—Temozolomide—skin cancer	6.27e-05	0.000692	CcSEcCtD
Zonisamide—Infection—Docetaxel—skin cancer	6.27e-05	0.000691	CcSEcCtD
Zonisamide—Nausea—Dactinomycin—skin cancer	6.23e-05	0.000687	CcSEcCtD
Zonisamide—Shock—Docetaxel—skin cancer	6.21e-05	0.000685	CcSEcCtD
Zonisamide—Nervous system disorder—Docetaxel—skin cancer	6.19e-05	0.000682	CcSEcCtD
Zonisamide—Pruritus—Fluorouracil—skin cancer	6.18e-05	0.000682	CcSEcCtD
Zonisamide—Thrombocytopenia—Docetaxel—skin cancer	6.18e-05	0.000681	CcSEcCtD
Zonisamide—Tachycardia—Docetaxel—skin cancer	6.16e-05	0.000679	CcSEcCtD
Zonisamide—Skin disorder—Docetaxel—skin cancer	6.13e-05	0.000676	CcSEcCtD
Zonisamide—SCN1A—Developmental Biology—RASA1—skin cancer	6.08e-05	0.00108	CbGpPWpGaD
Zonisamide—Vomiting—Temozolomide—skin cancer	6.03e-05	0.000665	CcSEcCtD
Zonisamide—Anorexia—Docetaxel—skin cancer	6.01e-05	0.000663	CcSEcCtD
Zonisamide—SCN5A—Axon guidance—RASA1—skin cancer	5.99e-05	0.00107	CbGpPWpGaD
Zonisamide—Rash—Temozolomide—skin cancer	5.98e-05	0.00066	CcSEcCtD
Zonisamide—Diarrhoea—Fluorouracil—skin cancer	5.98e-05	0.00066	CcSEcCtD
Zonisamide—Dermatitis—Temozolomide—skin cancer	5.98e-05	0.000659	CcSEcCtD
Zonisamide—SCN3B—Axon guidance—KRAS—skin cancer	5.96e-05	0.00106	CbGpPWpGaD
Zonisamide—SCN1B—Axon guidance—HRAS—skin cancer	5.96e-05	0.00106	CbGpPWpGaD
Zonisamide—SCN2B—Axon guidance—HRAS—skin cancer	5.96e-05	0.00106	CbGpPWpGaD
Zonisamide—Headache—Temozolomide—skin cancer	5.94e-05	0.000656	CcSEcCtD
Zonisamide—CA3—Metabolism—ENO2—skin cancer	5.91e-05	0.00105	CbGpPWpGaD
Zonisamide—Hypotension—Docetaxel—skin cancer	5.9e-05	0.00065	CcSEcCtD
Zonisamide—CA12—Metabolism—PLIN2—skin cancer	5.86e-05	0.00105	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—NRAS—skin cancer	5.81e-05	0.00104	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—NRAS—skin cancer	5.81e-05	0.00104	CbGpPWpGaD
Zonisamide—Dizziness—Fluorouracil—skin cancer	5.78e-05	0.000638	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Docetaxel—skin cancer	5.75e-05	0.000634	CcSEcCtD
Zonisamide—Insomnia—Docetaxel—skin cancer	5.71e-05	0.000629	CcSEcCtD
Zonisamide—SCN2B—Axon guidance—IL6—skin cancer	5.7e-05	0.00102	CbGpPWpGaD
Zonisamide—SCN1B—Axon guidance—IL6—skin cancer	5.7e-05	0.00102	CbGpPWpGaD
Zonisamide—CA1—C-MYB transcription factor network—KRAS—skin cancer	5.7e-05	0.00102	CbGpPWpGaD
Zonisamide—Paraesthesia—Docetaxel—skin cancer	5.67e-05	0.000625	CcSEcCtD
Zonisamide—Nausea—Temozolomide—skin cancer	5.64e-05	0.000622	CcSEcCtD
Zonisamide—Dyspnoea—Docetaxel—skin cancer	5.62e-05	0.00062	CcSEcCtD
Zonisamide—Somnolence—Docetaxel—skin cancer	5.61e-05	0.000619	CcSEcCtD
Zonisamide—CA14—Metabolism—CSPG4—skin cancer	5.61e-05	0.001	CbGpPWpGaD
Zonisamide—Vomiting—Fluorouracil—skin cancer	5.56e-05	0.000613	CcSEcCtD
Zonisamide—Dyspepsia—Docetaxel—skin cancer	5.55e-05	0.000613	CcSEcCtD
Zonisamide—Rash—Fluorouracil—skin cancer	5.51e-05	0.000608	CcSEcCtD
Zonisamide—Dermatitis—Fluorouracil—skin cancer	5.51e-05	0.000607	CcSEcCtD
Zonisamide—Decreased appetite—Docetaxel—skin cancer	5.48e-05	0.000605	CcSEcCtD
Zonisamide—Headache—Fluorouracil—skin cancer	5.48e-05	0.000604	CcSEcCtD
Zonisamide—CA5A—Metabolism—CSPG4—skin cancer	5.46e-05	0.000974	CbGpPWpGaD
Zonisamide—CA6—Metabolism—CSPG4—skin cancer	5.46e-05	0.000974	CbGpPWpGaD
Zonisamide—SCN4B—Axon guidance—HRAS—skin cancer	5.45e-05	0.000972	CbGpPWpGaD
Zonisamide—Gastrointestinal disorder—Docetaxel—skin cancer	5.45e-05	0.000601	CcSEcCtD
Zonisamide—Fatigue—Docetaxel—skin cancer	5.44e-05	0.0006	CcSEcCtD
Zonisamide—Constipation—Docetaxel—skin cancer	5.4e-05	0.000595	CcSEcCtD
Zonisamide—SCN4B—Developmental Biology—NRAS—skin cancer	5.32e-05	0.000948	CbGpPWpGaD
Zonisamide—SCN4B—Axon guidance—IL6—skin cancer	5.22e-05	0.00093	CbGpPWpGaD
Zonisamide—Feeling abnormal—Docetaxel—skin cancer	5.2e-05	0.000573	CcSEcCtD
Zonisamide—Nausea—Fluorouracil—skin cancer	5.19e-05	0.000573	CcSEcCtD
Zonisamide—Gastrointestinal pain—Docetaxel—skin cancer	5.16e-05	0.000569	CcSEcCtD
Zonisamide—CA5B—Metabolism—CSPG4—skin cancer	5.1e-05	0.000909	CbGpPWpGaD
Zonisamide—CA7—Metabolism—CSPG4—skin cancer	5.1e-05	0.000909	CbGpPWpGaD
Zonisamide—SCN3B—Axon guidance—HRAS—skin cancer	5.07e-05	0.000904	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—KRAS—skin cancer	5e-05	0.000892	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—KRAS—skin cancer	5e-05	0.000892	CbGpPWpGaD
Zonisamide—Body temperature increased—Docetaxel—skin cancer	4.99e-05	0.00055	CcSEcCtD
Zonisamide—Abdominal pain—Docetaxel—skin cancer	4.99e-05	0.00055	CcSEcCtD
Zonisamide—SCN3B—Developmental Biology—NRAS—skin cancer	4.94e-05	0.000881	CbGpPWpGaD
Zonisamide—SCN3B—Axon guidance—IL6—skin cancer	4.85e-05	0.000865	CbGpPWpGaD
Zonisamide—CA1—C-MYB transcription factor network—HRAS—skin cancer	4.84e-05	0.000863	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—CDK4—skin cancer	4.8e-05	0.000856	CbGpPWpGaD
Zonisamide—CA12—Metabolism—CSPG4—skin cancer	4.73e-05	0.000843	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PLIN2—skin cancer	4.68e-05	0.000834	CbGpPWpGaD
Zonisamide—Hypersensitivity—Docetaxel—skin cancer	4.65e-05	0.000513	CcSEcCtD
Zonisamide—SCN4B—Developmental Biology—KRAS—skin cancer	4.58e-05	0.000816	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—CDK4—skin cancer	4.55e-05	0.000811	CbGpPWpGaD
Zonisamide—Asthenia—Docetaxel—skin cancer	4.53e-05	0.000499	CcSEcCtD
Zonisamide—CA2—Metabolism—PLIN2—skin cancer	4.48e-05	0.000799	CbGpPWpGaD
Zonisamide—Pruritus—Docetaxel—skin cancer	4.46e-05	0.000492	CcSEcCtD
Zonisamide—Diarrhoea—Docetaxel—skin cancer	4.32e-05	0.000476	CcSEcCtD
Zonisamide—CA1—Metabolism—PLIN2—skin cancer	4.3e-05	0.000766	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—RASA1—skin cancer	4.28e-05	0.000762	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—KRAS—skin cancer	4.25e-05	0.000759	CbGpPWpGaD
Zonisamide—SCN2B—Developmental Biology—HRAS—skin cancer	4.25e-05	0.000758	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—HRAS—skin cancer	4.25e-05	0.000758	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PLIN2—skin cancer	4.21e-05	0.000751	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—CDK4—skin cancer	4.19e-05	0.000746	CbGpPWpGaD
Zonisamide—Dizziness—Docetaxel—skin cancer	4.17e-05	0.00046	CcSEcCtD
Zonisamide—SCN2B—Developmental Biology—IL6—skin cancer	4.07e-05	0.000726	CbGpPWpGaD
Zonisamide—SCN1B—Developmental Biology—IL6—skin cancer	4.07e-05	0.000726	CbGpPWpGaD
Zonisamide—AOX1—Disease—CSPG4—skin cancer	4.06e-05	0.000723	CbGpPWpGaD
Zonisamide—Vomiting—Docetaxel—skin cancer	4.01e-05	0.000442	CcSEcCtD
Zonisamide—Rash—Docetaxel—skin cancer	3.98e-05	0.000439	CcSEcCtD
Zonisamide—Dermatitis—Docetaxel—skin cancer	3.97e-05	0.000438	CcSEcCtD
Zonisamide—Headache—Docetaxel—skin cancer	3.95e-05	0.000436	CcSEcCtD
Zonisamide—CA13—Metabolism—PTGS2—skin cancer	3.92e-05	0.000699	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—HRAS—skin cancer	3.89e-05	0.000694	CbGpPWpGaD
Zonisamide—CA14—Metabolism—ENO2—skin cancer	3.81e-05	0.000679	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PLIN2—skin cancer	3.78e-05	0.000674	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CSPG4—skin cancer	3.77e-05	0.000672	CbGpPWpGaD
Zonisamide—Nausea—Docetaxel—skin cancer	3.75e-05	0.000413	CcSEcCtD
Zonisamide—CACNA1I—Axon guidance—NRAS—skin cancer	3.74e-05	0.000667	CbGpPWpGaD
Zonisamide—SCN4B—Developmental Biology—IL6—skin cancer	3.72e-05	0.000664	CbGpPWpGaD
Zonisamide—CA6—Metabolism—ENO2—skin cancer	3.71e-05	0.000662	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—ENO2—skin cancer	3.71e-05	0.000662	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—HRAS—skin cancer	3.62e-05	0.000645	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CSPG4—skin cancer	3.61e-05	0.000644	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PLIN2—skin cancer	3.56e-05	0.000635	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—NRAS—skin cancer	3.55e-05	0.000632	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—CDK4—skin cancer	3.54e-05	0.000631	CbGpPWpGaD
Zonisamide—CA7—Metabolism—ENO2—skin cancer	3.47e-05	0.000618	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—ENO2—skin cancer	3.47e-05	0.000618	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CSPG4—skin cancer	3.46e-05	0.000618	CbGpPWpGaD
Zonisamide—SCN3B—Developmental Biology—IL6—skin cancer	3.46e-05	0.000617	CbGpPWpGaD
Zonisamide—CA3—Metabolism—ERCC2—skin cancer	3.44e-05	0.000612	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—CDK4—skin cancer	3.43e-05	0.000611	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CSPG4—skin cancer	3.4e-05	0.000606	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—CDK4—skin cancer	3.37e-05	0.0006	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—CDK4—skin cancer	3.22e-05	0.000574	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—KRAS—skin cancer	3.22e-05	0.000574	CbGpPWpGaD
Zonisamide—CA12—Metabolism—ENO2—skin cancer	3.21e-05	0.000573	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—CDKN2A—skin cancer	3.2e-05	0.000571	CbGpPWpGaD
Zonisamide—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	3.17e-05	0.000565	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—CDK4—skin cancer	3.09e-05	0.000552	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—CDK4—skin cancer	3.09e-05	0.000552	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—KRAS—skin cancer	3.05e-05	0.000544	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CSPG4—skin cancer	3.05e-05	0.000543	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—CDK4—skin cancer	2.98e-05	0.000532	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CSPG4—skin cancer	2.87e-05	0.000512	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—NRAS—skin cancer	2.76e-05	0.000492	CbGpPWpGaD
Zonisamide—AOX1—Disease—ENO2—skin cancer	2.76e-05	0.000492	CbGpPWpGaD
Zonisamide—AOX1—Disease—SHH—skin cancer	2.76e-05	0.000492	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—HRAS—skin cancer	2.74e-05	0.000488	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—BRAF—skin cancer	2.74e-05	0.000488	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—NRAS—skin cancer	2.67e-05	0.000476	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—NRAS—skin cancer	2.67e-05	0.000476	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—NRAS—skin cancer	2.62e-05	0.000468	CbGpPWpGaD
Zonisamide—CACNA1I—Axon guidance—IL6—skin cancer	2.62e-05	0.000467	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—HRAS—skin cancer	2.59e-05	0.000463	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ENO2—skin cancer	2.56e-05	0.000457	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—NRAS—skin cancer	2.53e-05	0.000451	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—NRAS—skin cancer	2.51e-05	0.000447	CbGpPWpGaD
Zonisamide—SCN11A—Axon guidance—IL6—skin cancer	2.48e-05	0.000443	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ENO2—skin cancer	2.46e-05	0.000438	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—NRAS—skin cancer	2.41e-05	0.00043	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—NRAS—skin cancer	2.41e-05	0.00043	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.37e-05	0.000423	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—KRAS—skin cancer	2.37e-05	0.000423	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ENO2—skin cancer	2.35e-05	0.00042	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—NRAS—skin cancer	2.32e-05	0.000414	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ENO2—skin cancer	2.31e-05	0.000412	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—KRAS—skin cancer	2.3e-05	0.00041	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—KRAS—skin cancer	2.3e-05	0.00041	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—KRAS—skin cancer	2.26e-05	0.000403	CbGpPWpGaD
Zonisamide—AOX1—Disease—FOXO4—skin cancer	2.25e-05	0.000401	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PLIN2—skin cancer	2.23e-05	0.000398	CbGpPWpGaD
Zonisamide—CA14—Metabolism—ERCC2—skin cancer	2.21e-05	0.000395	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—KRAS—skin cancer	2.18e-05	0.000388	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—KRAS—skin cancer	2.16e-05	0.000385	CbGpPWpGaD
Zonisamide—CA6—Metabolism—ERCC2—skin cancer	2.16e-05	0.000385	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—ERCC2—skin cancer	2.16e-05	0.000385	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—CDK4—skin cancer	2.1e-05	0.000374	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—BRAF—skin cancer	2.1e-05	0.000374	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—KRAS—skin cancer	2.07e-05	0.00037	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—KRAS—skin cancer	2.07e-05	0.00037	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ENO2—skin cancer	2.07e-05	0.000369	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PTGS2—skin cancer	2.06e-05	0.000367	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—IL6—skin cancer	2.05e-05	0.000366	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—HRAS—skin cancer	2.02e-05	0.00036	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—ERCC2—skin cancer	2.01e-05	0.000359	CbGpPWpGaD
Zonisamide—CA7—Metabolism—ERCC2—skin cancer	2.01e-05	0.000359	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—KRAS—skin cancer	2e-05	0.000357	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—NRAS—skin cancer	1.97e-05	0.000351	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—HRAS—skin cancer	1.95e-05	0.000348	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—HRAS—skin cancer	1.95e-05	0.000348	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ENO2—skin cancer	1.95e-05	0.000348	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—IL6—skin cancer	1.93e-05	0.000344	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—HRAS—skin cancer	1.92e-05	0.000342	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—NRAS—skin cancer	1.91e-05	0.00034	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—NRAS—skin cancer	1.87e-05	0.000334	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—IL6—skin cancer	1.87e-05	0.000333	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—IL6—skin cancer	1.87e-05	0.000333	CbGpPWpGaD
Zonisamide—CA12—Metabolism—ERCC2—skin cancer	1.87e-05	0.000333	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—HRAS—skin cancer	1.85e-05	0.00033	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—IL6—skin cancer	1.84e-05	0.000327	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—HRAS—skin cancer	1.84e-05	0.000327	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CSPG4—skin cancer	1.8e-05	0.000321	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—NRAS—skin cancer	1.79e-05	0.000319	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—TP53—skin cancer	1.78e-05	0.000318	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—IL6—skin cancer	1.77e-05	0.000316	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—HRAS—skin cancer	1.76e-05	0.000314	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—HRAS—skin cancer	1.76e-05	0.000314	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—IL6—skin cancer	1.76e-05	0.000313	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—NRAS—skin cancer	1.72e-05	0.000307	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—NRAS—skin cancer	1.72e-05	0.000307	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—HRAS—skin cancer	1.7e-05	0.000303	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—KRAS—skin cancer	1.69e-05	0.000302	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—IL6—skin cancer	1.69e-05	0.000301	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—IL6—skin cancer	1.69e-05	0.000301	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—NRAS—skin cancer	1.66e-05	0.000296	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—KRAS—skin cancer	1.64e-05	0.000292	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—NRAS—skin cancer	1.63e-05	0.000291	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—IL6—skin cancer	1.63e-05	0.000291	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—IL6—skin cancer	1.63e-05	0.00029	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—KRAS—skin cancer	1.61e-05	0.000287	CbGpPWpGaD
Zonisamide—AOX1—Disease—ERCC2—skin cancer	1.6e-05	0.000286	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—KRAS—skin cancer	1.54e-05	0.000275	CbGpPWpGaD
Zonisamide—AOX1—Disease—TERT—skin cancer	1.5e-05	0.000268	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ERCC2—skin cancer	1.49e-05	0.000265	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—KRAS—skin cancer	1.48e-05	0.000264	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—KRAS—skin cancer	1.48e-05	0.000264	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—IL6—skin cancer	1.47e-05	0.000262	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—HRAS—skin cancer	1.44e-05	0.000257	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—KRAS—skin cancer	1.43e-05	0.000255	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ERCC2—skin cancer	1.43e-05	0.000254	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—KRAS—skin cancer	1.41e-05	0.000251	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—HRAS—skin cancer	1.39e-05	0.000249	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—IL6—skin cancer	1.38e-05	0.000246	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—HRAS—skin cancer	1.37e-05	0.000244	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ERCC2—skin cancer	1.37e-05	0.000244	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ERCC2—skin cancer	1.34e-05	0.000239	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—IL6—skin cancer	1.33e-05	0.000238	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTGS2—skin cancer	1.33e-05	0.000237	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—IL6—skin cancer	1.31e-05	0.000234	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—HRAS—skin cancer	1.31e-05	0.000234	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTGS2—skin cancer	1.29e-05	0.000231	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTGS2—skin cancer	1.29e-05	0.000231	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—HRAS—skin cancer	1.26e-05	0.000224	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—HRAS—skin cancer	1.26e-05	0.000224	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—HRAS—skin cancer	1.26e-05	0.000224	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—IL6—skin cancer	1.25e-05	0.000224	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ENO2—skin cancer	1.22e-05	0.000218	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—HRAS—skin cancer	1.21e-05	0.000216	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTGS2—skin cancer	1.21e-05	0.000215	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTGS2—skin cancer	1.21e-05	0.000215	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—IL6—skin cancer	1.2e-05	0.000215	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—IL6—skin cancer	1.2e-05	0.000215	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ERCC2—skin cancer	1.2e-05	0.000214	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—HRAS—skin cancer	1.2e-05	0.000213	CbGpPWpGaD
Zonisamide—AOX1—Disease—BRAF—skin cancer	1.19e-05	0.000212	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—NRAS—skin cancer	1.17e-05	0.000208	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—IL6—skin cancer	1.16e-05	0.000207	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—IL6—skin cancer	1.14e-05	0.000204	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ERCC2—skin cancer	1.13e-05	0.000202	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTGS2—skin cancer	1.12e-05	0.000199	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PLIN2—skin cancer	1.06e-05	0.000189	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—KRAS—skin cancer	1e-05	0.000179	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—HRAS—skin cancer	9.64e-06	0.000172	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTGS2—skin cancer	9.6e-06	0.000171	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTGS2—skin cancer	8.92e-06	0.000159	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTGS2—skin cancer	8.55e-06	0.000153	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—HRAS—skin cancer	8.53e-06	0.000152	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CSPG4—skin cancer	8.52e-06	0.000152	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTGS2—skin cancer	8.2e-06	0.000146	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—IL6—skin cancer	8.16e-06	0.000146	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTGS2—skin cancer	8.04e-06	0.000143	CbGpPWpGaD
Zonisamide—AOX1—Disease—NRAS—skin cancer	7.47e-06	0.000133	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTGS2—skin cancer	7.21e-06	0.000129	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ERCC2—skin cancer	7.11e-06	0.000127	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTGS2—skin cancer	6.8e-06	0.000121	CbGpPWpGaD
Zonisamide—AOX1—Disease—KRAS—skin cancer	6.43e-06	0.000115	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PLIN2—skin cancer	6.36e-06	0.000113	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ENO2—skin cancer	5.79e-06	0.000103	CbGpPWpGaD
Zonisamide—AOX1—Disease—HRAS—skin cancer	5.47e-06	9.75e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—IL6—skin cancer	5.23e-06	9.33e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CSPG4—skin cancer	5.13e-06	9.14e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.53e-06	8.08e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTGS2—skin cancer	4.26e-06	7.6e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ENO2—skin cancer	3.48e-06	6.21e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ERCC2—skin cancer	3.37e-06	6e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ERCC2—skin cancer	2.02e-06	3.61e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTGS2—skin cancer	2.02e-06	3.6e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTGS2—skin cancer	1.21e-06	2.16e-05	CbGpPWpGaD
